{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:04:15Z","timestamp":1784649855004,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012905","name":"Shandong Province Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH264"],"award-info":[{"award-number":["ZR2021MH264"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bone.2026.117935","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:31:51Z","timestamp":1778898711000},"page":"117935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K\/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation"],"prefix":"10.1016","volume":"210","author":[{"given":"Maosheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiao","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10169","key":"10.1016\/j.bone.2026.117935_bb0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-bioeng-062117-121139","article-title":"Bone mechanical properties in healthy and diseased states","volume":"20","author":"Morgan","year":"2018","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"10","key":"10.1016\/j.bone.2026.117935_bb0015","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0020","article-title":"The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"issue":"04","key":"10.1016\/j.bone.2026.117935_bb0025","first-page":"317","article-title":"Release of the results of the epidemiological survey on osteoporosis in China and the \u201chealthy bones\u201d special campaign","volume":"12","author":"Osteoporosis and Bone Mineral Disease Branch of Chinese Medical Association","year":"2019","journal-title":"Chin. J. Osteoporos. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2026.117935_bb0030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3803\/EnM.2021.301","article-title":"Long-term treatment of postmenopausal osteoporosis","volume":"36","author":"Brown","year":"2021","journal-title":"Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2026.117935_bb0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","article-title":"Epidemiology, etiology, and diagnosis of osteoporosis","volume":"194","author":"Lane","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.bone.2026.117935_bb0040","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1021\/acs.nanolett.2c04295","article-title":"Neutralization of intracellular pH homeostasis to inhibit osteoclasts based on a spatiotemporally selective delivery system","volume":"23","author":"Tian","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.bone.2026.117935_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jare.2023.01.003","article-title":"Obacunone targets macrophage migration inhibitory factor (MIF) to impede osteoclastogenesis and alleviate ovariectomy-induced bone loss","volume":"53","author":"He","year":"2023","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-022-00371-3","article-title":"Osteoporosis pathogenesis and treatment: existing and emerging avenues","volume":"27","author":"Liang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"6937","key":"10.1016\/j.bone.2026.117935_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bone.2026.117935_bb0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.bone.2026.117935_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2026.117935_bb0070","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1002\/jcp.27511","article-title":"Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism","volume":"234","author":"Jia","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.bone.2026.117935_bb0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0080","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-024-01451-x","article-title":"The essential role of combined calcium and vitamin D supplementation in the osteoporosis scenario in Italy: expert opinion paper","volume":"19","author":"Carugo","year":"2024","journal-title":"Arch. Osteoporos."},{"issue":"2","key":"10.1016\/j.bone.2026.117935_bb0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13346-022-01222-6","article-title":"Bone regeneration in osteoporosis: opportunities and challenges","volume":"13","author":"Patel","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04594-6","article-title":"Multifunctional gold nanoparticles for osteoporosis: synthesis, mechanism and therapeutic applications","volume":"21","author":"Gao","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41574-020-00426-5","article-title":"Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis","volume":"17","author":"Estell","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2026.117935_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101623","article-title":"The effect of osteoporosis treatment on bone mass","volume":"36","author":"Appelman-Dijkstra","year":"2022","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2026.117935_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70082","article-title":"Targeting endoplasmic reticulum stress-induced lymphatic dysfunction for mitigating bisphosphonate-related osteonecrosis","volume":"14","author":"Qin","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0110","article-title":"Exploring the classification and treatment of osteoporosis from the perspectives of natural medicines, molecular targets, and symptom clusters","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2026.117935_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107695","article-title":"Natural medicine in neuroprotection for ischemic stroke: challenges and prospective","volume":"216","author":"Tao","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bone.2026.117935_bb0120","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/med.21474","article-title":"Strategies to diversify natural products for drug discovery","volume":"38","author":"Li","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","article-title":"Network pharmacology in research of Chinese medicine formula: methodology, application and prospective","volume":"26","author":"Luo","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.bone.2026.117935_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.811331","article-title":"Comprehensive metabolomics and network pharmacology to explore the mechanism of 5-hydroxymethyl furfural in the treatment of blood deficiency syndrome","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bone.2026.117935_bb0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2018.12.112","article-title":"Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-\u03baB and JNK signaling pathways","volume":"509","author":"Chen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bone.2026.117935_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071052","article-title":"Coumarin ameliorates impaired bone turnover by inhibiting the formation of advanced glycation end products in diabetic osteoblasts and osteoclasts","volume":"10","author":"Lee","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.bone.2026.117935_bb0145","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.fitote.2012.04.020","article-title":"Flavonoids with antiplasmodial and cytotoxic activities of Macaranga triloba","volume":"83","author":"Zakaria","year":"2012","journal-title":"Fitoterapia"},{"issue":"6","key":"10.1016\/j.bone.2026.117935_bb0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ardp.201000233","article-title":"Synthesis and evaluation of antibacterial activities of 5,7-dihydroxycoumarin derivatives","volume":"344","author":"Chin","year":"2011","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bone.2026.117935_bb0155","article-title":"Spinosin suppresses RANKL-induced osteoclastogenesis and alleviates LPS-induced cranial osteolysis: a study based on network pharmacology and experimental validation","author":"Meng","year":"2025","journal-title":"Curr. Med. Chem."},{"issue":"15","key":"10.1016\/j.bone.2026.117935_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35374","article-title":"Suppressing ERp57 diminishes osteoclast activity and ameliorates ovariectomy-induced bone loss via the intervention in calcium oscillation and the calmodulin\/calcineurin\/Nfatc1 pathway","volume":"10","author":"Yuan","year":"2024","journal-title":"Heliyon"},{"issue":"16","key":"10.1016\/j.bone.2026.117935_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70044","article-title":"Crebanine mitigates glucocorticoid-induced osteonecrosis of the femoral head by restoring bone remodelling homeostasis via attenuating oxidative stress","volume":"28","author":"Dong","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.bone.2026.117935_bb0170","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1111\/cas.15557","article-title":"miR-92a-3p encapsulated in bone metastatic mammary tumor cell-derived extracellular vesicles modulates mature osteoclast longevity","volume":"113","author":"Uehara","year":"2022","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.bone.2026.117935_bb0175","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","article-title":"Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis","volume":"94","author":"Anonymous","year":"1993","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2026.117935_bb0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jbmr.4773","article-title":"Macrophages and bone remodeling","volume":"38","author":"Weivoda","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117935_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156205","article-title":"Damascenone inhibits osteoclastogenesis by epigenetically modulating Nrf2-mediated ROS scavenge and counteracts OVX-induced osteoporosis","volume":"135","author":"Ma","year":"2024","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.bone.2026.117935_bb0190","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"37","key":"10.1016\/j.bone.2026.117935_bb0195","doi-asserted-by":"crossref","first-page":"20383","DOI":"10.1021\/acs.jafc.4c02982","article-title":"Tetrahydroberberine prevents ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and promoting osteoclast apoptosis","volume":"72","author":"Wu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bone.2026.117935_bb0200","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.freeradbiomed.2025.06.043","article-title":"Idebenone attenuates RANKL-induced osteoclastogenesis and improves bone mass in ovariectomized mice","volume":"238","author":"Yu","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bone.2026.117935_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113622","article-title":"Thiaplakortone B attenuates RANKL-induced NF-\u03baB and MAPK signaling and dampens OVX-induced bone loss in mice","volume":"154","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bone.2026.117935_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115589","article-title":"Sofalcone inhibits osteoclastogenesis through Keap1\/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss","volume":"166","author":"Liang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bone.2026.117935_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01344","article-title":"Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis","volume":"10","author":"He","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bone.2026.117935_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1566772","article-title":"Blind docking methods have been inappropriately used in most network pharmacology analysis","volume":"16","author":"Che","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bone.2026.117935_bb0225","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/jm030580l","article-title":"The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures","volume":"47","author":"Wang","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bone.2026.117935_bb0230","article-title":"Research on the role and mechanism of the PI3K\/Akt\/mTOR signalling pathway in osteoporosis","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2026.117935_bb0235","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bone.2026.117935_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032652","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bone.2026.117935_bb0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","article-title":"Targeting the PI3K pathway in cancer: are we making headway?","volume":"15","author":"Janku","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bone.2026.117935_bb0250","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1007\/s12274-023-6224-7","article-title":"Liposomal-cyperone targeting bone resorption surfaces suppresses osteoclast differentiation and osteoporosis progression via the PI3K\/Akt axis","volume":"17","author":"Yang","year":"2024","journal-title":"Nano Res."},{"issue":"10","key":"10.1016\/j.bone.2026.117935_bb0255","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1007\/s11033-022-07747-w","article-title":"Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K\/AKT\/mTOR signaling pathway","volume":"49","author":"Jiang","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S8756-3282(01)00657-3","article-title":"The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation","volume":"30","author":"Lee","year":"2002","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2026.117935_bb0265","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","article-title":"Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases","volume":"56","author":"Takegahara","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.bone.2026.117935_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06263-4","article-title":"Exosome-targeted delivery of METTL14 regulates NFATc1 m6A methylation levels to correct osteoclast-induced bone resorption","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-023-00312-6","article-title":"Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity","volume":"12","author":"Hansen","year":"2024","journal-title":"Bone Res."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0280","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-024-00614-5","article-title":"New mechanistic understanding of osteoclast differentiation and bone resorption mediated by P2X7 receptors and PI3K-Akt-GSK3\u03b2 signaling","volume":"29","author":"Lu","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.1101254","article-title":"Akt induces osteoclast differentiation through regulating the GSK3\u03b2\/NFATc1 signaling cascade","volume":"188","author":"Moon","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4068\/cmj.2016.52.1.12","article-title":"Signaling pathways in osteoclast differentiation","volume":"52","author":"Kim","year":"2016","journal-title":"Chonnam Med. J."},{"issue":"8","key":"10.1016\/j.bone.2026.117935_bb0295","first-page":"1121","article-title":"Control of bone resorption by RANKL-RANK system","volume":"21","author":"Harada","year":"2011","journal-title":"Clin. Calcium"},{"key":"10.1016\/j.bone.2026.117935_bb0300","article-title":"Spinosin suppresses RANKL-induced osteoclastogenesis and alleviates LPS-induced cranial osteolysis: a study based on network pharmacology and experimental validation","volume":"32","author":"Meng","year":"2025","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bone.2026.117935_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-024-00799-7","article-title":"Exploring the therapeutic potential of isoorientin in the treatment of osteoporosis: a study using network pharmacology and experimental validation","volume":"30","author":"Zhang","year":"2024","journal-title":"Mol. Med."},{"issue":"7","key":"10.1016\/j.bone.2026.117935_bb0310","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.addr.2004.12.018","article-title":"Mechanism of osteoclast mediated bone resorption\u2014rationale for the design of new therapeutics","volume":"57","author":"Vaananen","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bone.2026.117935_bb0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2015.02.017","article-title":"Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-\u03baB and PI3K\/Akt signaling pathways","volume":"75","author":"Yuan","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117935_bb0320","doi-asserted-by":"crossref","DOI":"10.2174\/0113892037353878250212053910","article-title":"Network pharmacology and experiments to verify the effect and potential mechanism of baicalein on osteoporosis","volume":"26","author":"Xudong","year":"2025","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bone.2026.117935_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114898","article-title":"Pteryxin suppresses osteoclastogenesis and prevents bone loss via inhibiting the MAPK\/Ca2+ signaling pathways mediated by ROS","volume":"165","author":"Sun","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.bone.2026.117935_bb0330","article-title":"Daphnetin alleviates senile and disuse osteoporosis by distinct modulations of bone formation and resorption","volume":"11","author":"Gao","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"10.1016\/j.bone.2026.117935_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083650","article-title":"Mechanistic integration of network pharmacology and in vivo validation: TFRD combat osteoporosis via PI3K\/AKT pathway activation","volume":"26","author":"Tan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2026.117935_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157339","article-title":"Natural coumarins as anti-diabetic agents: mechanisms, therapeutic potential, and amelioration of diabetic complications","volume":"148","author":"Khatoon","year":"2025","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.bone.2026.117935_bb0345","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.7150\/ijbs.28609","article-title":"Umbelliferone prevents lipopolysaccharide-induced bone loss and suppresses RANKL-induced osteoclastogenesis by attenuating Akt-c-Fos-NFATc1 signaling","volume":"15","author":"Kwak","year":"2019","journal-title":"Int. J. Biol. Sci."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226001614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226001614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:28:05Z","timestamp":1784647685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":69,"alternative-id":["S8756328226001614"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117935","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5,7-Dihydroxycoumarin counteracts osteoporosis by inhibition of PI3K\/Akt signaling to suppress osteoclastogenesis: A study-based network pharmacology and experimental validation","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117935"}}